China-CEEC trade rises 11% in first half, customs data shows
BEIJING, July 16, 2026 /PRNewswire/ -- This is a report from China SCIO Trade between China and Central and Eastern European countries (CEEC) rose 11% year on year to 580.12 billion yuan (US$85.57 billion) in the first half of this year, continuing...
Clinicians Are Adopting AI to Solve the Documentation Crisis, New Global Survey Finds
New report finds 83% of clinicians adopted AI while workplace guidance and governance frameworks were still being developed. NEW YORK, July 16, 2026 /PRNewswire/ -- A survey of 1,823 clinicians across 25 countries has found healthcare professionals...
Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing
First-of-its-kind facility in Australia where radiopharmaceuticals are developed, manufactured and administered to patients under one roof. Patient care and research delivered in collaboration with the Melbourne Theranostic Innovation Centre (MTIC),...
Coremail Presents AI-Native Secure Email System at LEAP East 2026
HONG KONG, July 16, 2026 /PRNewswire/ -- From July 8 to 10, 2026, Coremail participated in the Asia LEAP East International Technology and Information Technology Exhibition 2026 held in Hong Kong, showcasing its Coremail AI-Native Secure Email...
Japanese investors offered final opportunity to own at Chelsea Residences by DAMAC in Dubai
TOKYO, July 16, 2026 /PRNewswire/ -- DAMAC Properties, the largest private real estate developer in the UAE and the Middle East, is set to unveil the sixth and final tower of Chelsea Residences by DAMAC at the Grand Ballroom, Mandarin Oriental on 17...
Copyright Cases Dominate as Regulatory and Product Liability Challenges Emerge in the Q2 2026 J.S. Held AI Disputes Monitor
Content-creator litigation grows more sophisticated as courts are asked to weigh in on how AI regulation. NEW YORK, July 16, 2026 /PRNewswire/ -- Global consulting firm J.S. Held today releases the Q2 2026 J.S. Held AI Disputes Monitor, the firm's...
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer treatment setting, building on the...
Webull Corporation Reports June 2026 Operating Data
ST. PETERSBURG, Fla., July 16, 2026 /PRNewswire/ -- Webull Corporation (NASDAQ: BULL) today reported select monthly operating data for June 2026. Registered Users at the end of June were 28.2 million (up approximately 200 thousand from the end of...